Mercury Antibiotics Private Limited
Produces pharmaceutical formulations for medical use.
1989 | Mumbai, Maharashtra (India) | Converted to LLP
Mercury Antibiotics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.34 M
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 8.86 Cr
- Revenue Growth -10.47%
- Profit Growth -29.77%
- Ebitda -106.40%
- Net Worth -22.79%
- Total Assets -22.52%
About Mercury Antibiotics
Mercury Antibiotics Private Limited (MAPL) is Converted To Llp company established on 23 Aug 1989 with its office registered at Mumbai, Maharashtra, India and has been running since 35 Year, 6 Months with a paid up capital of 2.34 M. According to MCA records, 3 Directors are linked to this company as of 04 Oct 2024.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231MH1989PTC137079
- Company No.
137079
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 1989
- Date of AGM
26 Aug 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Mercury Antibiotics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Shah  | Director | 01-Sep-1998 | Current |
Rajendrakumar Shah  | Director | 18-Aug-2005 | Current |
| Kaumudini Shah | Whole-Time Director | 04-Oct-1997 | Current |
Financial Performance of Mercury Antibiotics.
Mercury Antibiotics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.47% decrease. The company also saw a substantial fall in profitability, with a 29.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mercury Antibiotics?
In 2019, Mercury Antibiotics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mercury Laboratories LimitedDilip Shah and Rajendrakumar Shah are mutual person
- Mercury Antibiotics Llp
Kaumudini Shah is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹88.60 M
Charges Breakdown by Lending Institutions
- Others : 8.31 Cr
- Small Industries Development Bank Of India : 0.40 Cr
- State Bank Of India : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2011 | Others | ₹8.31 Cr | Satisfied |
| 28 Jun 2010 | Small Industries Development Bank Of India | ₹4.00 M | Satisfied |
| 16 Aug 2005 | State Bank Of India | ₹1.50 M | Satisfied |
How Many Employees Work at Mercury Antibiotics?
Unlock and access historical data on people associated with Mercury Antibiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mercury Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mercury Antibiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mercury Antibiotics
Recent activity within the organization
- Annual General Meeting
Mercury Antibiotics Private Limited last Annual general meeting of members was held on 26 Aug 2022 as per latest MCA records.
- Balance Sheet
Mercury Antibiotics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai.
- Charges
A charge registered on 28 Jun 2010 via Charge ID 10230645 with Small Industries Development Bank Of India was fully satisfied on 16 Mar 2020.
- Charges
A charge registered on 09 Sep 2011 via Charge ID 10309097 with Others was fully satisfied on 29 Feb 2020.
- Charges
A charge with Others of Rs. 83.10 M registered on 09 Sep 2011 with Charge ID 10309097 was modified on 31 Jul 2019.
- Charges
A charge with Others amounted to Rs. 83.10 M with Charge ID 10309097 was registered on 09 Sep 2011.
Frequently asked questions
What is the Incorporation or founding date of Mercury Antibiotics Private Limited?
Mercury Antibiotics Private Limited was incorporated on 23 Aug 1989.
What is authorized share capital and paid-up capital of Mercury Antibiotics Private Limited?
The authorized share capital of Mercury Antibiotics Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.34 M.
Who are the current board members & directors of Mercury Antibiotics Private Limited?
Currently 3 directors are associated with Mercury Antibiotics Private Limited.
- Dilip Ramanlal Shah
- Rajendrakumar Ramanlal Shah
- Kaumudini Rajendra Shah
What is the registered address of Mercury Antibiotics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mercury Antibiotics Private Limited is 18 Shreeji Bhuvan Mangaldas Road, Princess Street 1, Mumbai, Maharashtra, India, 400002.
What is the corporate identification number (CIN) and company number of Mercury Antibiotics Private Limited?
The corporate identification number (CIN) of Mercury Antibiotics Private Limited is U24231MH1989PTC137079 and the company number is 137079 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Mercury Antibiotics Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Mercury Antibiotics Private Limited has fallen by -10.47%.
What change has been observed in the net worth of Mercury Antibiotics Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Mercury Antibiotics Private Limited has experienced an downturn of -22.79%.
When was the last Balance Sheet of Mercury Antibiotics Private Limited filed with the ROC?
The most recent Balance Sheet for Mercury Antibiotics Private Limited was filed with the ROC on 31 Mar 2022.
People also Viewed
KS
Kishoriben ShahDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India